|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvalYear
|
1994
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
A10BA02
|
|
gptkbp:bioavailability
|
50-60%
|
|
gptkbp:brand
|
gptkb:Diabex
gptkb:Diaformin
gptkb:Metfogamma
gptkb:Metforal
gptkb:Metformin_Hydrochloride
gptkb:Riomet
gptkb:Siofor
gptkb:Obimet
gptkb:Fortamet
gptkb:Glucophage
gptkb:Glumetza
Glifage
Glycomet
|
|
gptkbp:CASNumber
|
657-24-9
|
|
gptkbp:contraindication
|
metabolic acidosis
renal impairment
hepatic impairment
|
|
gptkbp:discoveredBy
|
gptkb:Jean_Sterne
|
|
gptkbp:drugClass
|
biguanide
|
|
gptkbp:eliminationHalfLife
|
4-8.7 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:hasMolecularFormula
|
C4H11N5
|
|
gptkbp:hasTabletStrength
|
500 mg
1000 mg
850 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DB00857
|
|
gptkbp:isGeneric
|
yes
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
decreases hepatic glucose production
increases insulin sensitivity
|
|
gptkbp:metabolism
|
not metabolized
|
|
gptkbp:molecularWeight
|
129.164
|
|
gptkbp:name
|
gptkb:Metformin
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:proteinBinding
|
negligible
|
|
gptkbp:PubChem_CID
|
gptkb:DB00857
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gastrointestinal upset
lactic acidosis
|
|
gptkbp:synonym
|
gptkb:Glucophage
gptkb:Metformina
gptkb:Metformine
|
|
gptkbp:usedFor
|
gptkb:polycystic_ovary_syndrome
gptkb:type_2_diabetes_mellitus
|
|
gptkbp:bfsParent
|
gptkb:triclabendazole
|
|
gptkbp:bfsLayer
|
7
|